Cargando…

miRNAs in Lung Development and Diseases

The development of the lung involves a diverse group of molecules that regulate cellular processes, organ formation, and maturation. The various stages of lung development are marked by accumulation of small RNAs that promote or repress underlying mechanisms, depending on the physiological environme...

Descripción completa

Detalles Bibliográficos
Autores principales: Boateng, Eistine, Krauss-Etschmann, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216056/
https://www.ncbi.nlm.nih.gov/pubmed/32316149
http://dx.doi.org/10.3390/ijms21082765
_version_ 1783532330839703552
author Boateng, Eistine
Krauss-Etschmann, Susanne
author_facet Boateng, Eistine
Krauss-Etschmann, Susanne
author_sort Boateng, Eistine
collection PubMed
description The development of the lung involves a diverse group of molecules that regulate cellular processes, organ formation, and maturation. The various stages of lung development are marked by accumulation of small RNAs that promote or repress underlying mechanisms, depending on the physiological environment in utero and postnatally. To some extent, the pathogenesis of various lung diseases is regulated by small RNAs. In this review, we discussed miRNAs regulation of lung development and diseases, that is, COPD, asthma, pulmonary fibrosis, and pulmonary arterial hypertension, and also highlighted possible connotations for human lung health.
format Online
Article
Text
id pubmed-7216056
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72160562020-05-22 miRNAs in Lung Development and Diseases Boateng, Eistine Krauss-Etschmann, Susanne Int J Mol Sci Review The development of the lung involves a diverse group of molecules that regulate cellular processes, organ formation, and maturation. The various stages of lung development are marked by accumulation of small RNAs that promote or repress underlying mechanisms, depending on the physiological environment in utero and postnatally. To some extent, the pathogenesis of various lung diseases is regulated by small RNAs. In this review, we discussed miRNAs regulation of lung development and diseases, that is, COPD, asthma, pulmonary fibrosis, and pulmonary arterial hypertension, and also highlighted possible connotations for human lung health. MDPI 2020-04-16 /pmc/articles/PMC7216056/ /pubmed/32316149 http://dx.doi.org/10.3390/ijms21082765 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Boateng, Eistine
Krauss-Etschmann, Susanne
miRNAs in Lung Development and Diseases
title miRNAs in Lung Development and Diseases
title_full miRNAs in Lung Development and Diseases
title_fullStr miRNAs in Lung Development and Diseases
title_full_unstemmed miRNAs in Lung Development and Diseases
title_short miRNAs in Lung Development and Diseases
title_sort mirnas in lung development and diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216056/
https://www.ncbi.nlm.nih.gov/pubmed/32316149
http://dx.doi.org/10.3390/ijms21082765
work_keys_str_mv AT boatengeistine mirnasinlungdevelopmentanddiseases
AT kraussetschmannsusanne mirnasinlungdevelopmentanddiseases